Skip to search.
 TSX Up 0.37% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
296.74 Down 3.40(1.13%) 4:00PM EDT
|After Hours : 296.75 Up 0.01 (0.00%) 5:20PM EDT
Add to Portfolio
Prev Close:300.14
Open:300.41
Bid:296.75 x 200
Ask:300.00 x 200
1y Target Est:344.74
Beta:0.81
Next Earnings Date: 8-May-14REGN Earnings announcement
Day's Range:296.02 - 304.96
52wk Range:203.70 - 352.49
Volume:607,221
Avg Vol (3m):1,193,610
Market Cap:29.42B
P/E (ttm):77.88
EPS (ttm):3.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
REGNDown 1.13%29.42B
AMGNDown 0.07%87.17B
NVSUp 0.31%205.42B
RHHBYUp 0.14%123.01B

Key Statistics

Forward P/E (1 yr):43.32
P/S (ttm):14.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :4.35
Quarterly EPS Est (Mar-14) :0.94
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):2.38

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback